Small Stress Proteins, Biomarkers of Cancer

Small Stress Proteins and Human Diseases

Volumn , Issue , 2010, Pages 327-352

  Ciocca, Daniel R ^a   Fanelli, Mariel A ^a   Dario Cuello Carrion F ^a   Castro, Gisela N ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892070694     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (116)

1. Kampinga, HH; Hageman, J; Vos, MJ; Kubota, H; Tanguay, RM; Bruford, EA; Chetham, ME; Chen, B; Hightower, LE. (2009). Guidelines for the nomenclature of the human heat shock proteins. Cell Stress and Chaperones, 14:105-111.
2. Ciocca, DR; Fanelli, MA; Cuello-Carrión, FD; Calderwood, SK. (2007). Implications of heat shock proteins in carcinogenesis and cancer progression. In: S.K. Calderwood, M.Y. Sherman; D.R. Ciocca (Eds.), Heat Shock Proteins in Cancer. (Heat Shock Proteins, Vol 2. Series Ed.: A.A.A. Asea and S.K. Calderwood, pp. 31-51). The Netherlands:Springer.
3. Calderwood, SK; Khaleque MA; Sawyer, DB; Ciocca DR. (2007). Heat shock proteins in the progression of cancer. In: S.K. Calderwood (Ed.). Protein Reviews (Cell Stress Proteins, Vol 7. Series Ed.: M. Z. Atassi, pp. 422-450). New York:Springer Science.
4. Calderwood, SK; Khaleque, A; Sawyer, DB; Ciocca, DR. (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci, 31:164-172.
5. Ciocca, DR; Calderwood, SK. (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress and Chaperones, 10:86- 103.
6. Moyano, JV; Evans, JR; Chen, F; Lu, M; Werner, ME; Yehiely, F; Diaz, LK; Turbin, D; Karaca, G; Wiley, E; Nielsen, TO; Perou, CM; Cryns, V. (2006). αB-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest, 116:261-270.
7. Verrils, NM. (2006). Clinical proteomics: present and future prospects. Clin Biochem Rev, 27:99-116.
8. Yan, G; Li, L; Tao, Y; Liu, S; Liu, Y; Luo, W; Wu, Y; Tang, M; Dong, Z; Cao, Y. (2006). Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology. Proteomics, 6:1810- 1821.
9. Cho, WCS. (2007). Contribution of oncoproteomics to cancer biomarker discovery. Molecular Cancer 6:25-37.
10. Kabbage, M; Chahed, K; Hamrita, B; Guillier, CL; Trimeche, M; Remadi, S; Hoebeke, J; Chouchane, L. (2008). Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry. J Biomed Biotechnol, 2008: ID#564127 (10 pages).
11. Brozkova, K; Budinska, E; Bouchal, P; Hernychova, L; Knoflickova, D; Valik, D; Vyzula, R; Vojtesek, B; Nenutil, R. (2008). Surface-enhanced laser desorption/ionisation time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 10:R48.
12. Rakha, EA; Reis-Filho, JS, Ellis, IO. (2008). Impact of basal-like breast carcinoma determination for a more specific therapy. Pathobiology, 75:95-103.
13. Stice, JP; Knowlton, AA. (2008). Estrogen, NFkB, and the heat shock response. Mol Med, 14:517-527.
14. Lee, JW; Kwak, HJ; Lee, JJ; Kim, YN; Lee, JW; Park, MJ; Jung, SE; Hong, SI; Lee, JH; Lee, JS. (2008). HSP27 regulates cell adhesion and invasion via modulation of focal adhesion kinase and MMP-2 expression. Eur J Cell Biol 87:377-387.
15. Kang, SH; Kang, KW; Kim, K-H; Kwon, B; Kim, S-K; Lee, H-Y; Kong, S-Y; Lee, ES; Jang, S-G; Yoo, BC. (2008). Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer, 8:286.
16. Tchénio, T; Havard, M; Martinez, LA; Dautry, F. (2006). Heat shock-independent induction of multidrug resistance by heat shock factor 1. Mol Cell Biol, 26:580-591.
17. Ciocca, DR; Gago, FE; Fanelli, MA; Calderwood, SK. (2006). Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: clinical implications. J Steroid Biochem Mol Biol, 102:32-40.
18. Khaleque, A; Bharti, A; Gong, J; Ciocca, D; Stati, A; Fanelli, M; Calderwood, SK. (2008) Heat shock factor 1 represses estrogen dependent transcription through association with MTA1. Oncogene 27:1886-1893.
19. Fanelli, MA; Montt-Guevara, M; Diblasi, AM; Gago, FE; Tello, O; Cuello-Carrión, FD; Callegary, E; Bausero, MA; Ciocca, DR. (2008). P-cadherin and β-catenin are useful prognostic markers in breast cancer patients; β-catenin interacts with heat shock protein Hsp27. Cell Stress and Chaperones 13:207-220.
20. Bausero, MA; Bharti, A; Page, DT; Perez, KD; Eng, JWL; Jantschitsch, C; Kindas- Muegge, I; Ciocca, D; Asea, A. (2006). Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumor Biol, 27:17-26.
21. Zhang, D; Wong, LL; Koay, ESC. (2007). Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer. Mol Cancer, 6:52.
22. Gago, FE; Fanelli, MA; Ciocca DR (2006). Co-expression of steroid hormone receptors (estrogen receptor ? and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy. J Steroid Biochem Mol Biol, 98:36-40.
23. Vargas-Roig, LM; Gago, FE; Tello, O; Martin de Civetta, MT; Ciocca, DR. (1999). cerbB- 2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer (Pred Oncol), 84:129-134.
24. Vargas-Roig, LM; Gago, FE; Tello, O; Aznar, JC; Ciocca, DR (1998). Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer (Pred Oncol), 79:468-475.
25. Huthapisith, S; Layfield, R; Kerr, ID; Hughes, C; Eremin, O. (2007). Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anticancer drugs. Int J Oncol, 30:1545-1551.
26. Shi, P; Wang, MM; Jiang, LY; Liu, HT; Sun, JZ. (2008). Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression. Chin Med J (Engl), 121:1975-1979.
27. Smith, L; Welham, KJ; Watson, MB; Drew, PJ; Lind, MJ; Cawkwell, L. (2007). The proteomic analysis of cisplatin resistance in breast cancer cells. Oncol Res, 16:497-506.
28. Nadin, SB; Vargas-Roig, LM; Drago, G; Ibarra, J; Ciocca, DR. (2007). Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients. Cancer Lett, 252:131-146.
29. F.Mendez, F; Sandigursky, M; Franklin, WA; Kenny, MK; Kureekattil, R; Bases, R. (2000). Heat-shock proteins associated with base excision repair enzymes in HeLa cells. Radiat Res, 2:186-195.
30. Lee, H-J; Lee, Y-J; Kwon, H-C; Bae, S; Kim, S-H; Min, J-J; Cho, C-K; Lee, Y-S. (2006). Radioprotective effect of heat shock protein 25 on submandibular glands of rats. Am J Pathol, 169:1601-1611.
31. Ono, A; Kumai, T; Koizumi, H; Nishikawa, H; Kabayashi, S; Tadokoro, M. (2009). Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues. Human Pathol, 40:41-49.
32. Ciocca, DR; Puy, LA; Fasoli, LC. (1989). Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of endometrium and cervix. Cancer Res, 49:4298-4304.
33. Puy, LA; Lo Castro, G; Olcese, JE; Lotfi, HO; Brandi, HR; Ciocca, DR. (1989). Analysis of a 24-kilodalton (KD) protein in the human uterine cervix during abnormal growth. Cancer, 64:1067-1073.
34. Hoang, AT; Huang, J; Rudra-Ganguly, N; Zheng, J; Powell, WC; Rabindran, SK; Wu, C; Roy-Burman, P: (2000). A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am J Pathol, 156:857-864.
35. Glaessgen, A; Jonmarker, S; Lindberg, A; Nilsson, B; Lewensohn, R; Ekman, P; Valdman, A; Egevad, L. (2008). Heath shock proteins 27, 60 and 70 as prognostic markers of prostate cancer. APMIS, 116:888-895.
36. Miyake, H; Muramaki, M; Kurahashi, T; Takenaka, A; Fujisawa, M. (2008). Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Urol Oncol (Epub ahead of print).
37. El-Meghawry El-Kenawy, A; El-Kott, AF; Hasan, MS. (2008). Heat shock protein expresión independently predicts survival outcome in schistosomiasis-associated urinary bladder cancer. Int J Biol Markers, 23:214-218.
38. Hadaschik, BA; Jackson, J; Fazli, L; Zoubeidi, A, Burt, HM; Gleave, ME; So, AI. (2008). Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibited the growth of non-muscle-invasive bladder cancer. BJU Int, 102:610-616.
39. He, QY; Chen, J; Kung, HF; Yuen, AP; Chiu, JF. (2004). Identification of tumorassociated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics, 4:271-278.
40. Miyarek, AM; Balys, RL; Su, J; Hier, MP; Black, MJ; Alaoui-Jamali, MA. (2007). A cell proteomic approach for the diction of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch Otolarynol Head Neck Surg, 133:910-8.
41. Lo, W-Y; Tsai, M-H; Tsai, Y; Hua, Ch-H; Tsai, F-J; Huang, S-Y; Tsai, Ch-H; Lai, Ch- Ch. (2007). Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clinica Chimica Acta, 376:101-107.
42. Lo Muzio, L; Leonardi, R; Mariggiò, MA; Mignogna, MD; Rubini, C; Vinella, A; Pannone, G; Giannetti, L; Serpico, R; Testa, NF; De Rosa, G; Staibano, S. (2004). HSP27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol Histopathol, 19:119-128.
43. Lo Muzio, L; Campisi, G; Farina, A; Rubini, C; Ferrari, F; Falaschini, S; Leonardi, R; Carinci, F; Stalbano, S; De Rosa, G. (2006). Prognostic value of hsp27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours. Anticancer Res, 26:1343-1349.
44. Lee, JH; Sun, D; Cho, KJ; Kim, MS; Hong, MH; Kim, IK; Lee, JS; Lee, JH. (2007). Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay. J Cancer Res Clin Oncol, 133:37- 46.
45. Miyazaki, T; Kato, H; Faried, A; Sohda, M; Nakajima, M; Fukai, Y; Masuda, N; Manda, R; Fukuchi, M; Ojima, H; Tsukada, K; Kuwano, H. (2005). Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Anticancer Res, 25:2749-2755.
46. Langer, R; Ott, K; Specht, K; Becker, K; Lordick, F; Burian, M; Herrmann, K; Schrattenholz, A; Cahill, MA; Schwaiger, M; Hofler, H; Wester, HJ. (2008). Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response. Clin Cancer Res, 14:8279-8287.
47. Mazurov, VV; Solovieva, ME; Leshchenko, VV; Kruglov, AG; Edelweiss, EF; Yakubovskaya, RI; Akatov, VS. (2003). Small Heat shock protein hsp27 as a possible mediator of intercellular adhesion-induced drug resistance in human larynx carcinoma HRp-2 cells. Bioscience Reports, 23:187-197.
48. Aloy, M-T; Hadchity, E; Bionda, C; Diaz-Latud, Ch; Claude, L; Rousson, R; Arrigo, A-P; Rodríguez-Lafrasse, C. (2008). Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiation Oncology Biol Phys, 70:543-553.
49. Li, AF; Chau, GY; Chi, CW; Wu, CW; Huang, CL; LUI, WY. (2000). Prognostic significances of heat shock protein 27expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer, 88:2464-2470.
50. Luck, JM; Lam, CT; Siu, AF; Lam, BY; Ng, IO; HU MY; Che, CM; Fan, ST. (2006) Proteomic profiling of hepatocellular carcinoma in chinese cohort reveals heat shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics, 6:1049-1057.
51. Song, HY; Liu, YK; Feng, JT; Cui, JF; Dai, Z; Zhang, LJ; Feng, JX; Shen, HL; Tang, ZY. (2006). Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol, 132:92-98.
52. Matsushima-Nishiwaki, R; Takai S; Adachi, S; Minamitani, C; Yasuda, E; Noda, T; Kato, K; Toyoda, H; Kaneoka, Y; Yamaguchi, A; Kumada, T; Kozawa, O. (2008). Phosphorylated heat shock protein 27 represses growth hepatocellular carcinoma via inhibition of extracellular signal-regulated kinase. J Biol Chem, 283:18852-18860.
53. Romani, AA; Crafa, P; Desenzani, S; Graiani, G; Lagrasta, C; Sianesi, M; Soliani, P; Borghetti, AF. (2007). The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. BMC Cancer, 7:232.
54. Melle, Ch; Ernst, G; Escher, K; Hartmann, D; Schimmel, B; Bleul, A; Thieme, H; et al. (2007). Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clinical Chemistry, 53:629-635.
55. Mori-Iwamot, S; Kuramitsu, Y; Ryozawa, S; Mikuria, K; Fijumoto, M; Maehara, Y; Okita K; Nakamura, K; Saokaida, I. (2007). Proteomics finding of heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. International J Oncol, 31: 1345-1350.
56. Ren, H; Du, N; Liu, G; Hu, H-T; Tian, WDeng, Z-P; Shi J-S. (2006). Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation World J Gastroenterol, 12:2789-2792.
57. Cheng, Y; Zhang, J; Li, Y; Wang, Y; Gong, J. (2007). Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer, 7:191- 200.
58. Saito, H; Fukumoto, Y; Osaki, T; Fukuda, K; Tatebe, A; Tsujitani, S; Ikeguchi, M. (2006). Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg, 30:1864-1869.
59. Yang, YX; Xiao, ZQ; Chen, ZC; Zhang, GY; Yi, H; Zhang, PF; Li, JL; Zhu, G. (2006). Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics, 6:2009-2021.
60. Zhao, L; Liu, LI; Wang, Shuang; Zhang, Y-F; Yu, L; Ding Y-Q. (2007). Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. J Cancer Res Clin Oncol, 133: 771-782.
61. Doshi, BM; Hightower, LE; Lee, J. (2009). The role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock. Cell Stress Chaperones, (epub ahead of print). [62] Wong, CS; Wong, VW; Chan, CM; Ma, BB; Hui, EP; Wong, MC; Lam, MY; Au, TC; Chan, WH; Cheuk, W; Chan, AT. (2008). Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Oncol Rep, 20:89-98.
62. Tsuruta, M; Nishibori, H; Hasegawa, H; Ishii, Y; Kubota, T; Kitajima, M; Kitagawa, Y. (2008). Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Oncol Rep, 20:1165-1172.
63. Hoffman, PC; Mauer, AM; Vokes, EE. (2000). Lung Cancer. Lancet, 355:479-485.
64. Huang, Q; Zu, Y; Fu, X; Wu, T. (2005). Expression of heat shock protein 70 and 27 in non-small cell lung cancer and its clinical significance. J Huazhong Univ Sci Technolog Med Sci, 25:693-695.
65. Malusecka, E; Krzyzowska-Gruca, S; Gawrychowski, J; Fiszer-Kierzkowska, A; Kolosza, Z; Krawczyk, Z. (2008). Stress proteins Hsp27 and Hsp70i predict survival in non-small cell lung carcinoma. Anticancer Res, 28:501-506.
66. Wang, F; Feng, M; Xu, P; Xiao, H; Niu, P; Yang, X; Bai, Y; Peng, Y; Yao, P; Tan, H; Tanguay, RM; Wu, T. (2008). The level of Hsp27 in lymphocytes is negatively associated with a higher risk of lung cancer. Cell Stress & Chaperones (Epub ahead of print).
67. Berrieman, HK; Cawkwell, L; ÖKane, SL; Smith, L; Lind, MJ. (2006). Hsp27 may allow prediction of the response to single agent vinorelbine chemotherapy in non-small cell lung cancer. Oncology Reports, 15: 283-286.
68. Kim, EH; Lee, HJ; Lee, DH; Bae, S; Soh, JW; Jeoung, D; Kim, J; Cho, CK; Lee, YJ; Lee, YS. (2007). Inhibition of heat shock protein 27 mediated resistance to DNA damaging agents by a novel PKCdelta-V5 heptapeptide. Cancer Res, 67:6333-6341.
69. Thomas, X; Campos, L; Mounier, C; Cornillon, J; Flandrin, P; Le, QH; Piselli, S; Guyotat, D. (2005). Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res, 29:1049-1058.
70. Ramos, AM; Fernández, C; Amrán, D; Sancho, P; de Blas, E; Aller, P. (2005). Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Blood, 105:4013-4020.
71. Schepers, H; Geugien, M; van der Toorn, M; Bryantsev, AL; Kampinga, HH; Eggen, BJ; Vellenga, E. (2005). HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun. Exp Hematol. 33:660-670.
72. Navas, TA; Nguyen, AN; Hideshima, T; Reddy, M; Ma, JY; Haghnazari, E; Henson, M; Stebbins, EG; Kerr, I; O'Young, G; Kapoun, AM; Chakravarty, S; Mavunkel, B; Perumattam, J; Luedtke, G; Dugar, S; Medicherla, S; Protter, AA; Schreiner, GF; Anderson, KC; Higgins, LS. (2006). Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl- X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. Leukemia, 20:1017-27.
73. Mandal, C; Dutta, A; Mallick, A; Chandra, S; Misra, L; Sangwan, RS; Mandal, C. (2008). Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis, 13:1450-1464.
74. Zhang, ZX; Wen, FQ; Liu, ZP; Cheng, YD. (2008). Correlation of high expression of HSP27 to multidrug resistance of leukemia cell line K562/VCR. Ai Zheng, 27:348-353.
75. Verrills, NM; Liem, NL; Liaw, TY; Hood, BD; Lock, RB; Kavallaris, M. (2006). Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study. Proteomics, 6:1681-1694.
76. Tajeddine, N; Louis, M; Vermylen, C; Gala, JL; Tombal, B; Gailly, P. (2008). Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp27, p21, IL-8 and IGFBP-2 in vitro and in vivo. Leuk Lymphoma, 49:1123-1131.
77. Tajeddine, N; Gala, JL; Louis, M; Van Schoor, M; Tombal, B; Gailly, P. (2005). Tumor associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo. Cancer Res, 65:7348-7355.
78. Thomas, RK; Sos, ML; Zander, T; Mani, O; Popov, A; Berenbrinker, D; Smola-Hess, S; Schultze, JL; Wolf, J. (2005). Inhibition of nuclear translocation of nuclear factorkappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Clin Cancer Res, 11:8186-8194.
79. Chauhan, D; Li, G; Shringarpure, R; Podar, K; Ohtake, Y; Hideshima, T; Anderson, KC. (2003). Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells. Cancer Res, 63:6174-6177.
80. Debes, A; Oerding, M; Willers, R; Göbel, U; Wessalowski, R. (2003). Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin. Anticancer Res, 23:3359-3366.
81. Suehara, Y; Kondo, T; Fujii, K; Hasegawa, T; Kawai, A; Seki, K; Beppu, Y; Nishimura, T; Kurosawa, H; Hirohashi, S. (2006). Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics, 6:4402- 4409.
82. Ha, WY; Li, XJ; Yue, PY; Wong, DY; Yue, KK; Chung, WS; Zhao, L; Leung, PY; Liu, L; Wong, RN. (2006). Gene expression profiling of human synovial sarcoma cell line (Hs701.T) in response to IL-1beta stimulation. Inflamm Res, 55:293-299.
83. Zanini, C; Pulerà, F; Carta, F; Giribaldi, G; Mandili, G; Maule, MM; Forni, M; Turrini, F. (2008). Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma. Virchows Arch, 452:157-167.
84. Assimakopoulou, M; Sotiropoulou-Bonikou, G; Maraziotis, T; Varakis I. (1997). Prognostic significance of HSP-27 in astrocytic brain tumors: An immunohistochemical study. Anticancer Res, 17:2677-2682.
85. Golembieski, WA; Thomas, SL; Schultz, CR; Yunker; CK; McClung; HM; Lemke, N; Cazacu, S; Barker, T; Sage, EH; Brodie, C; Rempel, SA.(2008). HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion. Glia, 56:1061-1075.
86. Aloy, MT; Hadchity, E; Bionda, C; Diaz-Latoud, C; Claude, L; Rousson, R; Arrigo, AP; Rodriguez-Lafrasse, C. (2008). Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiat Oncol Biol Phys, 70:543-553.
87. Hauser, P; Hanzély, Z; Jakab, Z; Oláh, L; Szabó, E; Jeney, A; Schuler, D; Fekete, G; Bognár, L; Garami, M.(2006). Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma. J Pediatr Hematol Oncol, 28:461-466.
88. Kase S, Parikh JG, Rao N. (2008). Expression of heat shock protein 27 and alphacrystallins in human retinoblastoma after chemoreduction. Br J Ophthalmol, [Epub ahead of print]. [90] Mitsiades, N; Mitsiades, CS; Poulaki, V; Chauhan, D; Fanourakis, G; Gu, X; Bailey, C; Joseph, M; Libermann, TA; Treon, SP; Munshi, NC; Richardson, PG; Hideshima, T; Anderson, KC. (2002). Molecular sequelae of proteosome inhibition in human multiple myeloma cells. Proc Natl Acad Sci USA, 99:14374-14379.
89. Combaret, V; Boyault, S; Iacono, I; Brejon, S; Rousseau, R; Puisieux, A. (2008). Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity. Mol Cancer, 7:50.
90. Kang, SH; Fung, MA; Gandour-Edwards, R; Reilly, D; Dizon, T; Grahn, J; Isseroff, RR. (2004). Heat shock protein 27 is expressed in normal and malignant human melanocytes in vivo. J Cutan Pathol, 31:665-671.
91. Carta, F; Demuro, PP; Zanini, C; Santona, A; Castiglia, D; D'Atri, S; Ascierto, PA; Napolitano, M; Cossu, A; Tadolini, B; Turrini, F; Manca, A; Sini, MC; Palmieri, G; Rozzo, AC. (2005). Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res, 15:235-244.
92. Sosa, MS; Girotti, MR; Salvatierra, E; Prada, F; de Olmo, JA; Gallango, SJ; Albar, JP; Podhajcer, OL; Llera, AS. (2007). Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells. Proteomics, 7:4123-4134.
93. Shi, B; Grahn, JC; Reilly, DA; Dizon, TC; Isseroff, RR. (2008). Responses of the 27 kDa heat shock protein to UVB irradiation in human epidermal melanocytes. Exp Dermatol, 17:108-114.
94. Jantschitsch, C; Trautinger, F; Klosner, G; Gsur, A; Herbacek, I; Micksche, M; Kindås- Mügge, I. (2002). Overexpression of Hsp25 in K1735 murine melanoma cells enhances susceptibility to natural killer cytotoxicity. Cell Stress & Chaperones. 7:107-117.
95. Aldrian, S; Trautinger, F; Fröhlich, I; Berger, W; Micksche, M; Kindas-Mügge, I. (2002). Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress & Chaperones 7:177-185.
96. Berhane, T; Halliday, GM; Cooke, B; Barnetson, RS. (2002). Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol, 46:810-815.
97. Kiriyama, MT; Oka, M; Takehana, M; Kobayashi, S. (2001). Expression of a small heat shock protein 27 (HSP27) in mouse skin tumors induced by UVB-irradiation. Biol Pharm Bull, 24:197-200.
98. Trautinger, F; Kindas-Mügge, I; Dekrout, B; Knobler, RM; Metze, D. (1995). Expression of the 27-kDa heat shock protein in human epidermis and in epidermal neoplasms: an immunohistological study. Br J Dermatol, 133:194-202.
99. Aldrian, S; Kindas-Mügge, I; Trautinger, F; Fröhlich, I; Gsur, A; Herbacek, I; Berger, W; Micksche, M. (2003). Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system. Cell Stress & Chaperones 8:249-257.
100. Romanucci, M; Bongiovanni, L; Marruchella, G; Marà, M; di Guardo, G; Preziosi, R; della Salda, L. (2005). Heat shock proteins expression in canine intracutaneous cornifying epithelioma and squamous cell carcinoma. Vet Dermatol, 16:108-116.
101. Bongiovanni, L; Romanucci, M; Fant, P; Lagadic, M; Della Salda, L. (2008). Apoptosis and anti-apoptotic heat shock proteins in canine cutaneous infundibular keratinizing acanthomas and squamous cell carcinomas. Vet Dermatol, 19:271-279.
102. Gruvberger-Saal, SK; Parsons, R. (2006). Is the small heat shock protein alphaBcrystallin an oncogene?javascript:AL_get(this, 'jour', 'J Clin Invest.'); J Clin Invest, 116:30-32.
103. Arrigo, AP; Simon, A; Gibert, B; Kretz-Remy, C; Nivon, M; Czekalla, A; Guillet, D; Moulin, M; Diaz-Latoud, C; Vicart, P. (2007). Hsp27 (HspB1) and aB-crystallin (HspB5) as therapeutic targets. FEBS Lett, 581:3665-3674.
104. Dimberg, A, Rylova, S; Dieterich, LC; Olsson, A; Schiller, P; Wikner, C; Bohman, S; Botling, J; Lukinius, A; Wawrousek, EF; Claesson-Welsh, L (2008). aB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood, 111:2015-2023.
105. Aoyama, A, Steiger, R; Fröhli, E; Schäfer, R; von Deimling, A; Wiestler, O; Klemenz, R; (1993). Expression of alpha B-crystallin in human brain tumors. Int J Cancer, 55:760-764.
106. Pinder, SE; Balsitis, M; Ellis, IO; Landon, M; Mayer; RJ; Lowe, J. (1994). The expression of alpha B-crystallin in epithelial tumours: a useful tumour marker? J Pathol, 174:209-215.
107. Chin, D; Boyle, GM; Williams, RM; Ferguson, K; Pandeya, N; Pedley, J; Campbell, CM; Theile, DR; Parson, PG; Coman, WB. (2005). aB-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope, 115:1239-1242.
108. Sitterding, SM; Wiseman, WR; Schiller, CL; Luan, C; Chen, F; Moyano, JV; Watkin, WG; Wiley, EL; Cryns, VL; Diaz, LK. (2008). aB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas. Ann Diagn Pathol, 1:33-40.
109. Chelouche-Lev, D; Kluger, HM; Berger, AJ; Rimm, DL; Price, JE. (2004). aBcrystallin as a marker of lymph node involvement in breast carcinoma. Cancer, 100:2543-2548.
110. Ivanov, O; Chen, F; Wiley, EL; Keswani, A; Diaz, LK. (2008). aB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat, 111:411-417.
111. Bosman, JD; Yehiely, F; Evans, JR; Cryns, VL. (2009). Regulation of aB-crystallin gene expression by the transcription factor Ets1 in breast cancer. Breast Cancer Res Treat. [Epub ahead of print]. [114] Gober, MD; Smith, CC; Ueda, K; Toretsky, JA; Aurelian, L. (2003). Forced expression of the H11 heat shock protein can be regulated by DNA methylation and trigger apoptosis in human cells. J Biol Chem, 278:37600-37609.
112. Shemetov, AA; Seit-Nebi, AS; Gusev, NB.(2008) Structure, properties, and functions of the human small heat-shock protein HSP22 (HspB8, H11, E2IG1): a critical review. J Neurosci Res, 86:264-269.
113. Trent; S; Yang, C; Li; C; Lynch, M; Schmidt, EV. (2007). Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity. Cancer Res, 67:10774-10781.
114. Sun, X; Fontaine, JM; Bartl, I; Behnam, B; Welsh, MJ; Benndorf, R. (2007). Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptorpositive breast cancer cells. Cell Stress & Chaperones, 12:307-319.
115. Sharma, BK; Smith, CC; Laing, JM; Rucker, DA; Burnett, JW; Aurelian, L. (2006). Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions. Dermatology, 213:192-199.
116. Li, B; Smith, CC; Laing, JM; Gober, MD; Liu, L; Aurelian, L. (2007). Overload of the heat-shock protein H11/HspB8 triggers melanoma cell apoptosis through activation of transforming growth factor-beta-activated kinase 1. Oncogene, 26:3521-3531.